NONMEM Users Network Archive

Hosted by Cognigen

[NMusers] FDA-wide modeling and simulation

From: Wang, Yaning <Yaning.Wang_at_fda.hhs.gov>
Date: Fri, 13 Jul 2018 13:22:07 +0000

Dear all:
I would like to share a recent meeting recording. You can learn the applica=
tion and research in modeling and simulation across all FDA centers (CBER, =
CDER, CDRH, CFSAN, CTP, CVM, NCTR and ORA).

8:30

Welcoming Remarks
- Chief Scientists RADM Denise Hinton

8:45

Overview of ModSim WG & Accomplishments
- Tina Morrison, Chair, ModSim WG

9:05

Reports from each ModSim Interest Groups
- Big Data: Christopher Ellis, CDER
- Chemical Models: Patra Volarath, CFSAN
- Mechanistic Models: Maziar Kakhi, CDER
- Physics Models: Pras Pathmanathan, CDRH
- Risk Assessment: Annie Lumen, NCTR
- Statistical Models and Applications: Tomas Drgon, ORA

10:15

NETWORKING BREAK

10:45

Modeling Initiatives at FDA Centers
3-in-5 format (three slides in 5 mins)

     * Specific strategic priorities for your Center around M&S
     * What has changed in the last 5 years?
     * What do you anticipate in the next 5 years?
- CBER: Richard Forshee
- CDER: Yaning Wang
- CDRH: Tina Morrison
- CFSAN: Jane van Dorn
- CTP: Kausar Riaz Ahmed
- CVM: Marilyn Martinez
- NCTR: Huixiao Hong
- ORA: Tomas Drgon

11:45

LUNCH on your own

12:30

Reports from ModSim Implementation Teams
- Communications Plan: Ryan Ortega
- Successes & Opportunities for M&S: Pras Pathmanathan

12:50

Avicenna Alliance Update and Engagement with ModSimWG
- Dr. Markus Reiterer, International WG Leader

1:00

Keynote Presentations

  1. Dr. Keith Meintjes on Simulation Governance (confirmed)
  2. Dr. Markus Reiterer on Critical Thinking (confirmed)
     * The Role of Critical Thinking in the Assessment in Computer Modeli=
ng and Simulation

3:00

NETWORKING BREAK

3:30

Round-table Discussion about ModSim WG

  * Real-world evidence for model generation and validation
  * Machine learning applications
  * Digital transformation
  * CDER text mining and natural language processes WG
  * In silico clinical trials
  * Ideas for other implementation teams

4:30

Wrap-up




  * Part 1 Recording: https://collaboration.fda.gov/p81lvh7qzth/
  * Part 2 Recording: https://collaboration.fda.gov/p8nxta18f86/
  * Part 3 Recording: https://collaboration.fda.gov/p3pn29t4jjp/


Yaning Wang, Ph.D.
Director
Division of Pharmacometrics
Office of Clinical Pharmacology
Office of Translational Sciences
Center for Drug Evaluation and Research
Food and Drug Administration
Phone: 301-796-1624
Email: yaning.wang_at_fda.hhs.gov
Disclaimer: The contents of this message are mine personally and do not nec=
essarily reflect any position of the Government or the Food and Drug Admini=
stration.


Received on Fri Jul 13 2018 - 09:22:07 EDT

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to: nmusers-request@iconplc.com. Once subscribed, you may contribute to the discussion by emailing: nmusers@globomaxnm.com.